163 related articles for article (PubMed ID: 24578343)
1. IL-4 induces columnar-like differentiation of esophageal squamous epithelium through JAK/PI3K pathway: possible role in pathogenesis of Barrett's esophagus.
Shan J; Oshima T; Farre R; Fukui H; Watari J; Miwa H
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G641-9. PubMed ID: 24578343
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
3. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.
Clemons NJ; Wang DH; Croagh D; Tikoo A; Fennell CM; Murone C; Scott AM; Watkins DN; Phillips WA
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(12):G1335-46. PubMed ID: 23064761
[TBL] [Abstract][Full Text] [Related]
4. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
5. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 4 expressed in esophagitis induces a columnar phenotype in esophageal squamous cells.
Milano F; van Baal JW; Buttar NS; Rygiel AM; de Kort F; DeMars CJ; Rosmolen WD; Bergman JJ; VAn Marle J; Wang KK; Peppelenbosch MP; Krishnadath KK
Gastroenterology; 2007 Jun; 132(7):2412-21. PubMed ID: 17570215
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Notch signaling enhances transdifferentiation of the esophageal squamous epithelium towards a Barrett's-like metaplasia via KLF4.
Vega ME; Giroux V; Natsuizaka M; Liu M; Klein-Szanto AJ; Stairs DB; Nakagawa H; Wang KK; Wang TC; Lynch JP; Rustgi AK
Cell Cycle; 2014; 13(24):3857-66. PubMed ID: 25558829
[TBL] [Abstract][Full Text] [Related]
9. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux.
Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546
[TBL] [Abstract][Full Text] [Related]
10. [Biopsy methods and pathology of Barrett's esophagus].
Takubo K; Honma N; Sawabe M; Arai T; Tanaka Y; Kino K; Iwakiri K
Nihon Rinsho; 2005 Aug; 63(8):1429-33. PubMed ID: 16101234
[TBL] [Abstract][Full Text] [Related]
11. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.
Tselepis C; Perry I; Dawson C; Hardy R; Darnton SJ; McConkey C; Stuart RC; Wright N; Harrison R; Jankowski JA
Oncogene; 2002 Sep; 21(39):6071-81. PubMed ID: 12203119
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis resistance in Barrett's esophagus: ex vivo bioassay of live stressed tissues.
Dvorakova K; Payne CM; Ramsey L; Bernstein H; Holubec H; Chavarria M; Bernstein C; Sampliner RE; Riley C; Prasad A; Garewal H
Am J Gastroenterol; 2005 Feb; 100(2):424-31. PubMed ID: 15667503
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide could promote development of Barrett's esophagus by
Fujiya T; Asanuma K; Koike T; Okata T; Saito M; Asano N; Imatani A; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2022 Jan; 322(1):G107-G116. PubMed ID: 34786954
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
16. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
[TBL] [Abstract][Full Text] [Related]
17. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
18. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology.
MacLennan AJ; Orringer MB; Beer DG
Mol Carcinog; 1999 Feb; 24(2):137-43. PubMed ID: 10078941
[TBL] [Abstract][Full Text] [Related]
19. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers.
Chen X; Qin R; Liu B; Ma Y; Su Y; Yang CS; Glickman JN; Odze RD; Shaheen NJ
BMC Gastroenterol; 2008 Jan; 8():1. PubMed ID: 18190713
[TBL] [Abstract][Full Text] [Related]
20. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
